An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.
Experimental Treatment Gaining Traction Via Social Media
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to message these accounts privately for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a robust trade exists on Telegram, where communities with thousands of members share comparison images, administration instructions and claims of rapid UK delivery. Vendors market the substance there before redirecting customers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Professionals Voice Concerns
However, physicians and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could result in individuals injecting products of uncertain source.
Several experts stated the popularity for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some content creators try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer laws, potentially leading to penalties, legal action or imprisonment.
Service Response and Material Removal
Based on the social media company, the service has removed problematic material and banned associated keywords and search suggestions. The organization stated it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.
Online Marketplace Activities
Research also found communities with up to 9,000 members selling the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays groups with numerous of users, populated with photos of weight loss, positive reviews and step-by-step instructions for preparing or injecting at home.
Within minutes of joining one group, a seller shared WhatsApp details, where most transactions take place. The vendor provided an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.
Item Information and Pricing
Within these communities, posts display black plastic packages with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When asked how long a pen should last, sellers give contradictory answers ranging from a several days to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for Telegram stated it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering substances they can’t verify. Although the research behind retatrutide is valid, these digital versions may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.
Her staff has already seen individuals harmed by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may subject users to possibly significant medical dangers”.
